CheckMyRecalls

DRG International, Inc. recalls DRG:HYBRiD-XL Insulin

Published
22 Jan 2025
Units affected
10 units
Agency
FDA
Country
United States

The hazard

The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361

Brand / company
DRG International, Inc.
Codes / lots
UDI: (01)04048474053616(17)20251130(10)429K084-1. Lot Number: 429K084-1
Distribution
Worldwide - US Nationwide distribution in the state of New Jersey and the countries of Czechia and Romania.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 22 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.